• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.26% Nasdaq Down 0.34%

    XOMA Corporation (XOMA)

    -NasdaqGM
    3.86 Up 0.14(3.62%) Jul 6, 4:00PM EDT
    |After Hours : 3.86 0.00 (0.00%) Jul 6, 5:59PM EDT
    Add to Portfolio
    Prev Close:3.73
    Open:3.71
    Bid:3.70 x 3100
    Ask:3.88 x 4700
    1y Target Est:9.17
    Beta:3.88
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:3.66 - 3.90
    52wk Range:2.92 - 5.95
    Volume:2,421,437
    Avg Vol (3m):2,450,260
    Market Cap:454.77M
    P/E (ttm):N/A
    EPS (ttm):-0.69
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for XOMA

    Comparison

    Symbol% ChgMkt Cap
    XOMAUp 3.62%454.77M
    NVSDown 1.18%238.69B
    REGNUp 0.23%53.91B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):24.24
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.64
    Quarterly EPS Est (Jun-15) :-0.18
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):-0.34

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback